NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

LeMaitre Vascular, Inc. (LMAT) Stock Analysis

LeMaitre Vascular, Inc. (LMAT) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

LMAT

$80.67

+$0.18 (+0.22%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare LMAT with… →

LMAT Key Statistics

As of Sep 4, 2026
Trading
Open
$79.22
Previous Close
$80.49
Day's Range
79.04–81.00
52-Week Range
78.27–118.01
Volume
167.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.49
Valuation
Market Cap
$1.84B
P/E Ratio
28.21
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
25.38
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.13
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
7.03
EPS (ttm)Profit attributable to each share over the last twelve months.
2.86
Financials (FY)
Revenue (FY)
$249.60M+13.53%
Net Income (FY)
$57.73M+31.10%
Profit marginThe share of revenue left as profit after all costs and taxes.
25.02%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
22.87M
1-Year Return
−16.30%
Dividend and dates
Dividend
$1.00+1.24%
Ex-Dividend Date
August 20, 2026
Earnings Date
November 5, 2026estimated
Avg Volume
370.32K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

LMAT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−0.05%
2025−11.16%
2024+63.63%
2023+24.60%
2022−7.40%
2021+25.10%
2020+14.09%
2019+53.77%
2018−25.13%
2017+26.58%
2016 (partial year)+47.82%

As of September 4, 2026.

LMAT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$249.60M$57.73M23.1%
2024$219.86M$44.04M20.0%
2023$193.48M$30.11M15.6%
2022$161.65M$20.64M12.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$249.60M$178.54M$67.91M$57.73M23.1%
2024$219.86M$150.90M$52.26M$44.04M20.0%
2023$193.48M$127.05M$37.20M$30.11M15.6%
2022$161.65M$104.90M$29.94M$20.64M12.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

LMAT Dividend History

$0.80+25.0% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$0.753—
2025$0.804+25.0%
2024$0.644+14.3%
2023$0.564+12.0%
YearDividends per sharePaymentsChange
2026 (partial year)$0.753—
2025$0.804+25.0%
2024$0.644+14.3%
2023$0.564+12.0%
2022$0.504+13.6%
2021$0.444+15.8%
2020$0.384+11.8%
2019$0.344+21.4%
2018$0.284+27.3%
2017$0.224+388.9%
2016$0.051—

Most recent payment: $0.25 per share, ex-dividend August 20, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

LMAT Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricLMATMedical Instruments & Supplies medianvs median
P/E28.2135.6121% below
P/S ratio7.033.17122% above
Profit margin25.02%0.85%24.2 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 10 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

LeMaitre Vascular, Inc. (LMAT) is capitalised at $1.84B on the latest close. The company sits in the Healthcare sector, in the Medical Instruments & Supplies industry. The company reports 646 employees.

LMAT last closed at $80.67 on September 4, 2026. That is +$0.18 (+0.22%) against the previous close. The 52-week range on file runs from $78.27 to $118.01. The latest close sits 3.07% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $249.60M. That is +13.53% against the prior fiscal year, when revenue was $219.86M. Net income for the same year was $57.73M. That is +31.10% against the prior fiscal year. Profit margin runs at 25.02%. That is 24.2 percentage points above the Medical Instruments & Supplies median of 0.85%. Earnings per share on a trailing basis come to 2.86.

Across the 4 fiscal years on file, revenue moves from $161.65M in 2022 to $249.60M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

LMAT trades at a trailing price-to-earnings ratio of 28.21. That is 20.79% below the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 25.38. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.13. The price-to-sales ratio is 7.03. On price-to-sales that is 121.57% above the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned −16.30%. Measured over 10 years, that is +17.04% a year compounded. Beta against the wider market is reported at 0.49. Daily returns over the trailing 10 years annualize to a volatility of 41.82%.

Growth & Income

LMAT pays a dividend yielding 1.24%. That is 0.3 percentage points above the Medical Instruments & Supplies median yield of 0.97%. The indicated annual rate is $1.00 a share. The ex-dividend date on file is August 20, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.75 a share. The year before, 2025, totalled $0.80 a share.

So far in 2026 the price is −0.05%. Across the complete calendar years on file, 2024 returned +63.63% and 2018 returned −25.13%. Of the 9 complete calendar years on file, 6 finished higher.

Peer Comparison

LeMaitre Vascular, Inc. (LMAT) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
LeMaitre Vascular, Inc. LMAT $1.84B 28.2
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. LeMaitre Vascular, Inc. trades at a P/E of 28.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Visit website →